Young, L. R., Franz, D. N., Nagarkatte, P., Fletcher, C. D. M., Wikenheiser-Brokamp, K. A., Galsky, M. D., . . . McCormack, F. X. (2009). Utility of [(18)F]2-Fluoro-2-Deoxyglucose-PET in Sporadic and Tuberous Sclerosis-Associated Lymphangioleiomyomatosis. American College of Chest Physicians.
Stile di citazione ChicagoYoung, Lisa R., et al. Utility of [(18)F]2-Fluoro-2-Deoxyglucose-PET in Sporadic and Tuberous Sclerosis-Associated Lymphangioleiomyomatosis. American College of Chest Physicians, 2009.
Citazione MLAYoung, Lisa R., et al. Utility of [(18)F]2-Fluoro-2-Deoxyglucose-PET in Sporadic and Tuberous Sclerosis-Associated Lymphangioleiomyomatosis. American College of Chest Physicians, 2009.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.